日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Clinical Implication of Pemafibrate, a Novel Selective PPARα Modulator

新型选择性PPARα调节剂Pemafibrate的临床意义

Fujioka, Yoshio

Does Pemafibrate Lower Low-Density Lipoprotein-Cholesterol?

培马贝特能降低低密度脂蛋白胆固醇吗?

Fujioka, Yoshio

Increased Red Cell Superoxide Dismutase Activity Is Associated with Cancer Risk: A Hidaka Cohort Study

红细胞超氧化物歧化酶活性升高与癌症风险相关:一项日高队列研究

Tanaka, Shin-Ichiro; Fujioka, Yoshio; Tsujino, Takeshi; Ishida, Tatsuro; Hirata, Ken-Ichi

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

日本动脉粥样硬化学会(JAS)2022年动脉粥样硬化性心血管疾病预防指南

Okamura, Tomonori; Tsukamoto, Kazuhisa; Arai, Hidenori; Fujioka, Yoshio; Ishigaki, Yasushi; Koba, Shinji; Ohmura, Hirotoshi; Shoji, Tetsuo; Yokote, Koutaro; Yoshida, Hiroshi; Yoshida, Masayuki; Deguchi, Juno; Dobashi, Kazushige; Fujiyoshi, Akira; Hamaguchi, Hirotoshi; Hara, Masumi; Harada-Shiba, Mariko; Hirata, Takumi; Iida, Mami; Ikeda, Yoshiyuki; Ishibashi, Shun; Kanda, Hideyuki; Kihara, Shinji; Kitagawa, Kazuo; Kodama, Satoru; Koseki, Masahiro; Maezawa, Yoshiro; Masuda, Daisaku; Miida, Takashi; Miyamoto, Yoshihiro; Nishimura, Rimei; Node, Koichi; Noguchi, Midori; Ohishi, Mitsuru; Saito, Isao; Sawada, Shojiro; Sone, Hirohito; Takemoto, Minoru; Wakatsuki, Akihiko; Yanai, Hidekatsu

Association between urinary N-acetyl-β-glucosaminidase activity-urinary creatinine concentration ratio and risk of disability and all-cause mortality

尿液N-乙酰-β-氨基葡萄糖苷酶活性与尿肌酐浓度比值与残疾风险和全因死亡率之间的关联

Tanaka, Shin-Ichiro; Fujioka, Yoshio; Tsujino, Takeshi; Ishida, Tatsuro; Hirata, Ken-Ichi

Problems that Physicians should Notice for Better Treatment of Hypercholesterolemia in Japan

日本医生应注意哪些问题以更好地治疗高胆固醇血症?

Fujioka, Yoshio

Impact of serum cholesterol esterification rates on the development of diabetes mellitus in a general population

血清胆固醇酯化率对一般人群糖尿病发生发展的影响

Tanaka, Shin-Ichiro; Fujioka, Yoshio; Tsujino, Takeshi; Ishida, Tatsuro; Hirata, Ken-Ichi

Effects of a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator K-877 (Pemafibrate) on Postprandial hyperlipidemia

新型选择性过氧化物酶体增殖物激活受体α调节剂K-877(培马贝特)对餐后高脂血症的影响

Fujioka, Yoshio

Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?

肠道菌群中的短链脂肪酸是炎症和动脉粥样硬化的防御因素吗?

Ohira, Hideo; Tsutsui, Wao; Fujioka, Yoshio

Is the Association between Dietary Trans Fatty Acids and Insulin Resistance Remarkable in Japan?

日本膳食反式脂肪酸与胰岛素抵抗之间的关联是否显著?

Tsutsui, Wao; Fujioka, Yoshio